Media Advisory: Stem Cell Board to Consider State Legislation: Special Presentation on Stem Cell Research and Damaged Blood Vessels

The Independent Citizens Oversight Committee (ICOC), governing board for the state agency charged with managing the $3 billion California stem cell research program, will meet Tuesday, April 10, 2007.

 WHO: The 29-member Independent Citizens Oversight Committee (ICOC) is the governing board for the California Institute for Regenerative Medicine (CIRM). The list of members is available at http://www.cirm.ca.gov/faq/pdf/Members.pdf.

 WHAT: The ICOC is expected to adopt a position on SB 771, a legislative proposal that would set requirements for revenue-sharing and access to therapies for recipients of stem cell research grants. The agenda for the meeting is available at http://www.cirm.ca.gov/meetings/2007/04-10-07.asp.

  The ICOC will hear a special presentation on patients living with peripheral vascular disease and damaged blood vessels by Janet Wright, M.D., a cardiologist and members of the ICOC; John R. Laird, M.D., Medical Director of the UC Davis Vascular Center; and Jan Nolta, Ph.D., Director of the UC Davis Stem Cell Program.  

WHEN:
Tuesday, April 10, 2007
8:00 a.m. to 12:30 p.m. (estimated)
Sacramento, CA 95814
WHERE:
Sacramento Convention Center
1400 J Street, Rooms 203 and 204

 WHY: To date, the ICOC has approved stem cell research grants totaling more than $158 million to 23 academic and non-profit research institutions in California. The ICOC has developed regulatory policies governing grants to both for-profit and non-profit entities. If adopted, SB 771 would supersede those regulations.

 

Contacts:  Dale A. Carlson 
                 
415/396-9117  

 

© 2013 California Institute for Regenerative Medicine